Point-of-Care Testing

News on technologies and applications for point-of-care testing.

Mar 10, 2022

Oxford BioDynamics Gathering Real-World Data on Checkpoint Inhibitor Response Predictor
Premium

Feb 25, 2022

Duke Cancer Institute Expanding Molecular Tumor Board Access to Rural, Underserved Communities
Premium

Feb 17, 2022

Mass General, Lunaphore Technologies to Develop Test to Predict PARP Inhibitor Response

Feb 8, 2022

A2 Biotherapeutics Enrolling Patients in Clinical Study of New CAR-T Therapy Using Tempus NGS Panel
Premium

Jan 27, 2022

Epic Sciences, Biosplice Therapeutics Partner on Multiomic Profiling for Cancer Trials

Jan 11, 2022

Biofidelity Prepares to Launch Lung Cancer Mutation Detection Assay
Premium

Jan 10, 2022

Caris Life Sciences, HotSpot Therapeutics Partner to Develop Precision Medicines, CDx Tests

Jan 10, 2022

Grail Partners With Premier's PINC AI to Improve Patient Access to Blood-Based Multi-Cancer Test

Nov 11, 2021

Lucence, Veterans' Affairs Health Care System Launch Liquid Biopsy Screening Study

Nov 3, 2021

Yemaachi Biotech, Lucence Aim to Improve Genomic Breast Cancer Testing in Ghana and Beyond
Premium

Sep 21, 2021

Data Demonstrates Lucence Liquid Biopsy Test Can Track Treatment-Based ctDNA Changes
Premium

Sep 20, 2021

OncoHost Further Assessing Protein Signature for Predicting NSCLC Patients' Immunotherapy Response
Premium

Aug 31, 2021

Oxford BioDynamics Awarded Grant to Apply EpiSwitch to ICI Cancer Therapy Response

Mar 17, 2021

Bio-Techne Seeks to Build Out 'Substantial Diagnostics Presence' With Asuragen Buy
Premium

Mar 16, 2021

Abviris Raises Almost $2.4M to Expand Use of HPV-Related Cancer Test

Jan 12, 2021

Moffitt Cancer Center, Exuma Biotech Partner to Advance Point-of-Care CAR T-cell Therapy Program

Oct 14, 2020

Inspirata Partners With Carebox Healthcare on Automated Cancer Clinical Trial Matching

Aug 16, 2019

Xylonix, BioGemex Ink MOU to Develop Point-of-Care Cancer Immunotherapy-Response Diagnostic

Apr 10, 2019

Georgia Tech, Emory Developing Urine-Based Dx to Guide Cancer Immunotherapies
Premium